Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report

BACKGROUND: Atypical BCR-ABL1 transcripts are detected in less than 5% of patients diagnosed with chronic myeloid leukaemia (CML), of which e19a2 is the most frequently observed, with breakpoints in the micro breakpoint cluster region (μ-BCR) and coding for the p230 BCR-ABL1 protein. p230 CML is ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerveira, Nuno, Ferreira, Rosa Branca, Bizarro, Susana, Correia, Cecília, Torres, Lurdes, Lisboa, Susana, Vieira, Joana, Santos, Rui, Campilho, Fernando, Pinho Vaz, Carlos, Leite, Luís, Teixeira, Manuel R., Campos, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286606/
https://www.ncbi.nlm.nih.gov/pubmed/30526517
http://dx.doi.org/10.1186/s12885-018-5100-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286606/
https://www.ncbi.nlm.nih.gov/pubmed/30526517
http://dx.doi.org/10.1186/s12885-018-5100-4

Ejemplares similares